Dynamic interaction between T cell-mediated β-cell damage and β-cell repair in the run up to autoimmune diabetes of the NOD mouse

Physiological Genomics

Volumn 21, Issue , 2005, Pages 201-211

  Vukkadapu, Sankaranand S ^a   Belli, Jenine M ^a   Ishii, Koji ^a   Jegga, Anil G ^a   Button, John J ^a   Aronow, Bruce J ^a   Katz, Jonathan D ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression profile; Microarray; Nonobese diabetic mouse; Pancreas; Type 1 diabetes

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL ADHESION; CELL COMMUNICATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; FUNCTIONAL GENOMICS; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REG3ALPHA GENE; REG3BETA GENE; REG3GAMMA GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; AUTOANTIGENS; CELL ADHESION MOLECULES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DIABETES MELLITUS, TYPE 1; INFLAMMATION; INSULIN-SECRETING CELLS; INTEGRINS; KINETICS; MICE; MICE, INBRED NOD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES;

EID: 21244465464     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00173.2004     Document Type: Article

References (67)

1. Aarvak T, Chabaud M, Miossec P, and Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162: 1246-1251, 1999.
2. Adams JC. Thrombospondin-1. Int J Biochem Cell Biol 29: 861-865, 1997.
3. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, and Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278: 1910-1914, 2003.
4. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, and Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA 93: 2260-2263, 1996.
5. Angelastro JM, Ignatova TN, Kukekov VG, Steindler DA, Stengren GB, Mendelsohn C, and Greene LA. Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J Neurosci 23: 4590-4600, 2003.
6. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, and Hamann A. P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385: 81-83, 1997.
7. Benjamini R and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc B57: 289-300, 1995.
8. Bradley LM, Asensio VC, Schioetz LK, Harbertson J, Krahl T, Patstone G, Woolf N, Campbell IL, and Sarvetnick N. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162: 2511-2520, 1999.
9. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, and Eizirik DL. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276: 48879-8886, 2001.
10. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
11. Cunningham J, Leffell M, Mearkle P, and Harmatz P. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication. Metabolism 44: 996-999, 1995.
12. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, and Chinnaiyan AM. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826, 2001.
13. + cotransporter (NKCCl) in asthmatic subjects. Genome Res 11: 1473-1483, 2001.
14. Dusetti NJ, Frigerio JM, Keim V, Dagorn JC, and Iovanna JL. Structural organization of the gene encoding the rat pancreatitis-associated protein. Analysis of its evolutionary history reveals an ancient divergence from the other carbohydrate-recognition domain-containing genes. J Biol Chem 268: 14470-14475, 1993.
15. Eaves IA, Wicker LS, Ghandour G, Lyons PA, Peterson LB, Todd JA, and Glynne RJ. Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes. Genome Res 12: 232-243, 2002.
16. Eckenrode SE, Ruan Q, Yang P, Zheng W, McIndoe RA, and She JX. Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice. Diabetes 53: 366-375, 2004.
17. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, and Flamme I. Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278: 7520-7530, 2003.
18. Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, and Koch CJ. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. Br J Cancer 72: 875-882, 1995.
19. Gerard C and Rollins BJ. Chemokines and disease. Nat Immun 2: 108-115, 2001.
20. Gurr W, Yavari R, Wen L, Shaw M, Mora C, Christa L, and Sherwin RS. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes 51: 339-346, 2002.
21. Haskins K, Portas M, Bradley B, Wegmann D, and Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37: 1444-1448, 1988.
22. Hill NJ, Van Gunst K, and Sarvetnick N. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. J Immunol 170: 1649-1658, 2003.
23. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, and Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15, 2003.
24. Jakubowski A, Ehrenfels BN, Pepinsky RB, and Burkly LC. Vascular cell adhesion molecule-Ig fusion protein selectively targets activated α4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice. J Immunol 155: 938-946, 1995.
25. Jegga AG, Sherwood SP, Carman JW, Pinski AT, Phillips JL, Pestian JP, and Aronow BJ. Detection and visualization of compositionally similar cis-regulatory element clusters in orthologous and coordinately controlled genes. Genome Res 12: 1408-1417, 2002.
26. Ji B, Chen XQ, Misek DE, Kuick R, Hanash S, Ernst S, Najarian R, and Logsdon CD. Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiol Genomics 14: 59-72, 2003.
27. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, and Pelletier JP. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J Immunol 160: 3513-3521, 1998.
28. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, and Kent WJ. The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-54, 2003.
29. Karp CL, Grupe A, Schadt E, Ewart SL, Keane-Moore M, Cuomo PJ, Kohl J, Wahl L, Kuperman D, Germer S, Aud D, Peltz G, and Wills-Karp M. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immun 1: 221-226, 2000.
30. Katz J, Benoist C, and Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 23: 3358-3360, 1993.
31. Katz JD, Benoist C, and Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188, 1995.
32. Katz JD, Wang B, Haskins K, Benoist C, and Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100, 1993.
33. Kurrer MO, Pakala SV, Hanson HL, and Katz JD. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94: 213-218, 1997.
34. Li B, Yu H, Zheng W, Voll R, Na S, Roberts AW, Williams DA, Davis RJ, Ghosh S, and Flavell RA. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288: 2219-2222, 2000.
35. Li X, Chen H, and Epstein PN. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J Biol Chem 279: 765-771, 2004.
36. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508, 2002.
37. Lu B, Ferrandino AF, and Flavell RA. Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat Immun 5: 38-44, 2004.
38. Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ, and Flavell RA. GADD45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14: 583-590, 2001.
39. Lu M, Seufert J, and Habener JF. Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 272: 28349-28359, 1997.
40. Makino S and Tochino Y. The spontaneously non-obese diabetic mouse. Exp Anim 27: 27-29, 1978.
41. Mathis D, Vence L, and Benoist C. β-Cell death during progression to diabetes. Nature 414: 792-798, 2001.
42. Nadler ST and Attie AD. Please pass the chips: genomic insights into obesity and diabetes. J Nutr 131: 2078-2081, 2001.
43. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, and Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387, 2002.
44. Narushima Y, Unno M, Nakagawara K, Mori M, Miyashita H, Suzuki Y, Noguchi N, Takasawa S, Kumagai T, Yonekura H, and Okamoto H. Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIIIα, RegIIIβ, RegIIIγ. Gene 185: 159-168, 1997.
45. Pakala SV, Chivetta M, Kelly CB, and Katz JD. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189: 1053-1062, 1999.
46. Penkowa M, Espejo C, Martinez-Caceres EM, Poulsen CB, Montalban X, and Hidalgo J. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J Neuroimmunol 119: 248-260, 2001.
47. Prochazka M, Gaskins HR, Shultz LD, and Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89: 3290-3294, 1992.
48. Stenina OI, Krukovets I, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, and Plow EF. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker-rat. Circulation 107: 3209-3215, 2003.
49. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, Meneses JJ, Pedersen RA, Rubenstein JL, and German MS. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 125: 2213-2221, 1998.
50. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, and Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669, 2000.
51. Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, and Okamoto H. A novel gene activated in regenerating islets. J Biol Chem 263: 2111-2114, 1988.
52. Tisch R and McDevitt H. Insulin-dependent diabetes mellitus. Cell 85: 291-297, 1996.
53. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, and McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75, 1993.
54. Todd JA and Wicker LS. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15: 387-395, 2001.
55. Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, and Goldfeld AE. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 20: 6084-6094, 2000.
56. Tsukamoto K, Yokono K, Amano K, Nagata M, Yagi N, Tominaga Y, Moriyama H, Miki M, Okamoto N, Yoneda R, Inoue Y, Yagita H, Okumura K, and Kasuga M. Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice. Cell Immunol 165: 193-201, 1995.
57. Ukkola O, Erkkila PH, Savolainen MJ, and Kesaniemi YA. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249: 451-459, 2001.
58. Unno M, Nata K, Noguchi N, Narushima Y, Akiyama T, Ikeda T, Nakagawa K, Takasawa S, and Okamoto H. Production and characterization of Reg knockout mice: reduced proliferation of pancreatic β-cells in Reg knockout mice. Diabetes 51, Suppl 3: S478-S483, 2002.
59. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, and Goronzy JJ. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol 164: 2947-2954, 2000.
60. Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, and Lowik CW. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis 61: 870-876, 2002.
61. Ward SG and Westwick J. Chemokines: understanding their role in T-lymphocyte biology. Biochem J 333: 457-470, 1998.
62. Webster NJ, Kong Y, Cameron KE, and Resnik JL. An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes 43: 305-312, 1994.
63. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pruss M, Reuter I, and Schacherer F. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 28: 316-319, 2000.
64. Yan SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM, Cooper DR, Steinberg SF, Mackman N, Pinsky DJ, and Stern DM. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274: 15030-15040, 1999.
65. Yang XD, Michie SA, Mebius RE, Tisch R, Weissman I, and McDevitt HO. The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy. Diabetes 45: 705-710, 1996.
66. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, and Spriggs MK. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821, 1995.
67. Zimmer Y, Milo-Landesman D, Svetlanov A, and Efrat S. Genes induced by growth arrest in a pancreatic beta cell line: identification by analysis of cDNA arrays. FEBS Lett 457: 65-70, 1999.